Related Experiment Video
Updated: Oct 4, 2025
13:04
In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
13.4K
Combined Oral Contraceptive Use and Breast Cancer Risk: Select Considerations for Clinicians
Nursing for Women'S Health
|February 8, 2022
Summary
Combined oral contraceptives (COCs) are widely used for various health benefits. Research on COCs and breast cancer risk shows varied results, influenced by factors like hormone type and duration of use.
Area of Science:
- Reproductive health
- Oncology
- Endocrinology
Background:
- Combined oral contraceptives (COCs) are frequently prescribed for contraception and non-contraceptive reasons.
- Concerns persist regarding a potential link between COC use and increased breast cancer risk.
- Existing research presents inconsistent findings on this association.
Purpose of the Study:
- To review and synthesize current evidence on the relationship between combined oral contraceptive use and breast cancer risk.
- To provide clinicians with information to aid in counseling patients about potential risks.
- To highlight factors that may influence the association between COCs and breast cancer.
Main Methods:
- Literature review of studies investigating combined oral contraceptive use and breast cancer.
- Analysis of factors such as hormone type, duration of use, and patient age.
- Synthesis of varied research outcomes to identify trends and discrepancies.
Main Results:
- Study results on COC use and breast cancer risk are inconsistent.
- Factors like specific hormone composition, duration of use, and individual patient age may modify the risk.
- Further research is needed to clarify the complex relationship.
Conclusions:
- The relationship between combined oral contraceptives and breast cancer risk is complex and not fully elucidated.
- Clinicians should consider individual patient factors when discussing the risks and benefits of COCs.
- Ongoing research is crucial for definitive conclusions regarding COC-associated breast cancer risk.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
190
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
190
01:22Birth Control Methods
3.6K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
3.6K
02:59Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.4K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.4K
01:12Relative Risk
472
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
472
01:21Drug Dosing: Obese Patients
8
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
8